Gemina, Bb Boy .
HRN: 21-83-11 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/22/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/22/2022
08/29/2022
IVTT
54mg
Q24
Psnb
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes